Lawmakers press for transparency as advisory council advises on Alaska’s RHTP

Joint House and Senate Health and Social Services Committees · February 12, 2026

Loading...

AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

Lawmakers questioned whether the Department of Health or the commissioner will have final say on awards and sought clarity on advisory‑council roles; presenters said the council is directional and the department will use a data‑driven evaluation process with the Alaska Community Foundation as subgrant administrator.

Committee members pressed presenters about governance, transparency and the legislature’s role in overseeing the RHTP awards process.

Senator Dunbar asked whether the advisory council’s recommendations could be overridden by a single executive decision, noting the amount at stake. Monique Martin and other presenters said the Department of Health plans a "robust, data‑driven" evaluation and identified the Alaska Community Foundation as the subgrant administrator for initial letters of interest; presenters described the advisory council’s role as directional rather than final decision‑maker.

Lawmakers raised concern about opaque scoring or last‑minute changes that could shift awards. Jared Kosen urged legislative oversight through hearings and public review rather than direct appropriation authority, arguing oversight and accountability are the legislature’s most effective levers without delaying award distribution.

Senator Giesel reported that the presiding officers from both legislative bodies have requested nonvoting legislative representation on the advisory council; presenters said that nonvoting legislative seats will be accommodated to improve transparency. The committee members asked for detailed rubrics and public reporting so that applicants and the public can understand how projects are scored and selected.

No formal policy or rule changes were adopted at the hearing; presenters said they would bring concerns about transparency and legislative involvement back to the Department of Health.